lobbying_activities: 951924
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 951924 | 10f277a0-633e-4e8d-8a07-65792150dbf6 | Q2 | MEHLMAN CONSULTING, INC. | 284950 | AMERICAN CLINICAL LABORATORY ASSOCIATION | 2010 | second_quarter | MED | Health reform law implementation issues including application of medical device tax to clinical laboratory tests and cut to laboratory fee schedule update. H.R. 4213/S. 3551, American Jobs and Closing Tax Loopholes Act of 2010: health care provisions including physician payment (SGR), FMAP and Cobra. H.R. 5440, Genomics and Personalized Medicine Act of 2010: FDA oversight of laboratory developed tests (LDTs). | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2010-07-13T16:56:41.587000-04:00 |